pioglitazone has been researched along with Active Hyperemia in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the effects of pioglitazone (30 mg once daily for 16 weeks) on insulin sensitivity, insulin-mediated vasodilation, vascular inflammatory markers, fat distribution and lipids in Asian Indians and Caucasians of European ancestry." | 7.73 | Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians. ( Gerhard-Herman, MD; O'connor, ME; Raji, A; Simonson, DC; Williams, JS, 2006) |
| "To determine the effects of pioglitazone (30 mg once daily for 16 weeks) on insulin sensitivity, insulin-mediated vasodilation, vascular inflammatory markers, fat distribution and lipids in Asian Indians and Caucasians of European ancestry." | 3.73 | Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians. ( Gerhard-Herman, MD; O'connor, ME; Raji, A; Simonson, DC; Williams, JS, 2006) |
| "The study included 15 subjects with type 2 diabetes with normoalbuminuria (age, 60." | 2.73 | Short-term low-dosage pioglitazone treatment improves vascular dysfunction in patients with type 2 diabetes. ( Kashiwagi, A; Maeda, K; Maegawa, H; Nakao, K; Nishio, Y; Ugi, S; Uzu, T, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raji, A | 1 |
| Gerhard-Herman, MD | 1 |
| Williams, JS | 1 |
| O'connor, ME | 1 |
| Simonson, DC | 1 |
| Maegawa, H | 1 |
| Nishio, Y | 1 |
| Nakao, K | 1 |
| Ugi, S | 1 |
| Maeda, K | 1 |
| Uzu, T | 1 |
| Kashiwagi, A | 1 |
1 trial available for pioglitazone and Active Hyperemia
| Article | Year |
|---|---|
Short-term low-dosage pioglitazone treatment improves vascular dysfunction in patients with type 2 diabetes.
Topics: Adiponectin; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Angiopathies; | 2007 |
1 other study available for pioglitazone and Active Hyperemia
| Article | Year |
|---|---|
Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians.
Topics: Adipose Tissue; Administration, Sublingual; Adult; Aged; Biomarkers; Blood Glucose; Brachial Artery; | 2006 |